過敏性腸症候群(Irritable Bowel Syndrome)：世界の治験レビュー（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Irritable Bowel Syndrome 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Irritable Bowel Syndrome 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Irritable Bowel Syndrome Therapeutics Clinical Trials 32
Prominent Drugs 33
Latest Clinical Trials News on Irritable Bowel Syndrome 34
Dec 18, 2014: Synergy Pharmaceuticals Initiates First Phase 3 Clinical Trial of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation 34
Nov 20, 2014: Ironwood Earns $15 Million Milestone from Astellas upon Initiation of Enrollment in Linaclotide Phase III IBS-C Clinical Trial in Japan 34
Nov 04, 2014: Ironwood Pharmaceuticals Initiates Phase III Trial of 72 mcg Linaclotide in Adult Patients with Chronic Idiopathic Constipation 35
Oct 21, 2014: Synergy Pharmaceuticals Presents Positive Phase 2b Study Results for Plecanatide in Patients with Irritable Bowel Syndrome with Constipation 35
Oct 21, 2014: Salix’s TARGET 3 Study Examines the Safety and Efficacy of Repeat Treatment with Rifaximin 550 mg for Irritable Bowel Syndrome with Diarrhea 36
Oct 17, 2014: Salix Pharmaceuticals Outlines Data of Rifaximin Presents at American College of Gastroenterology 2014 Annual Scientific Meeting 38
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
GlaxoSmithKline plc 39
Clinical Trial Overview of GlaxoSmithKline plc 39
Novartis AG 43
Clinical Trial Overview of Novartis AG 43
Actavis plc 45
Clinical Trial Overview of Actavis plc 45
Astellas Pharma Inc. 46
Clinical Trial Overview of Astellas Pharma Inc. 46
Salix Pharmaceuticals Ltd. 47
Clinical Trial Overview of Salix Pharmaceuticals Ltd. 47
Ironwood Pharmaceuticals, Inc. 48
Clinical Trial Overview of Ironwood Pharmaceuticals, Inc. 48
AstraZeneca PLC 49
Clinical Trial Overview of AstraZeneca PLC 49
Ono Pharmaceutical Co., Ltd. 50
Clinical Trial Overview of Ono Pharmaceutical Co., Ltd. 50
Almirall, S.A. 51
Clinical Trial Overview of Almirall, S.A. 51
A. Menarini Industrie Farmaceutiche Riunite Srl 52
Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl 52
Clinical Trial Overview of Top Institutes / Government 53
Mayo Clinic 53
Clinical Trial Overview of Mayo Clinic 53
University of North Carolina 54
Clinical Trial Overview of University of North Carolina 54
University of Nottingham 55
Clinical Trial Overview of University of Nottingham 55
Maastricht University Medical Center 56
Clinical Trial Overview of Maastricht University Medical Center 56
Sahlgrenska University Hospital 57
Clinical Trial Overview of Sahlgrenska University Hospital 57
Chinese University of Hong Kong 58
Clinical Trial Overview of Chinese University of Hong Kong 58
Cedars-Sinai Medical Center 59
Clinical Trial Overview of Cedars-Sinai Medical Center 59
Karolinska Institute 60
Clinical Trial Overview of Karolinska Institute 60
University of California, Los Angeles 61
Clinical Trial Overview of University of California, Los Angeles 61
Baylor College of Medicine 62
Clinical Trial Overview of Baylor College of Medicine 62
Five Key Clinical Profiles 63
Appendix 155
Abbreviations 155
Definitions 155
Research Methodology 156
Secondary Research 156
About GlobalData 157
Contact Us 157
Disclaimer 157
Source 157